Abstract
Autoantibodies to the C3 convertase of the alternative pathway of complement, called C3 nephritic factors (C3NeF), cause persistently low C3 in the circulation and production of C3 degradation fragments due to prolonged stabilization of the C3 convertase. C3NeF are associated with glomerulopathy, acquired partial lipodystrophy, and less frequently with increased susceptibility to meningococcal infection. Analysis of C3NeF is an important part of the diagnostic workup of C3 glomerulopathy, but their identification is difficult presumably due to considerable heterogeneity. Therefore it is recommended to use a combination of different analysis methods for the detection of C3NeF. Here we present an ELISA method for detection of C3NeF.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Riedl M, Thorner P, Licht C (2017) C3 Glomerulopathy. Pediatr Nephrol 32(1):43–57
Egan M, Sullivan K, Frazer-Abel A, Cunningham-Rundles C (2016) A healthy female with C3 hypocomplementemia and C3 nephritic factor. Clin Immunol 169:14–15
Karstorp A (1976) C3 activator and hypocomplementaemia in a "healthy" woman. Br Med J 1(6008):501–502
Daha MR, Fearon DT, Austen KF (1976) C3 nephritic factor (C3NeF): stabilization of fluid phase and cell-bound alternative pathway convertase. J Immunol 116(1):1–7
Misra A, Peethambaram A, Garg A (2004) Clinical features and metabolic and autoimmune derangements in acquired partial lipodystrophy: report of 35 cases and review of the literature. Medicine (Baltimore) 83(1):18–34
Teisner B, Elling P, Svehag SE et al (1984) C3 nephritic factor in a patient with recurrent Neisseria meningitidis infections. Acta Pathol Microbiol Immunol Scand C 92(6):341–349
Daha MR, Van Es LA (1981) Stabilization of homologous and heterologous cell-bound amplification convertases, C3bBb, by C3 nephritic factor. Immunology 43(1):33–38
Paixão-Cavalcante D, López-Trascasa M, Skattum L et al (2012) Sensitive and specific assays for C3 nephritic factors clarify mechanisms underlying complement dysregulation. Kidney Int 82(10):1084–1092
Scott DM, Amos N, Sissons JG et al (1978) The immunoglobulin nature of nephritic factor (NeF). Clin Exp Immunol 32(1):12–24
Rother U (1982) A new screening test for C3 nephritis factor based on a stable cell bound convertase on sheep erythrocytes. J Immunol Methods 51(1):101–107
Peters DK, Martin A, Weinstein A et al (1972) Complement studies in membranoproliferative glomerulonephritis. Clin Exp Immunol 11:311–320
Williams DG, Peters DK, Fallows J et al (1974) Studies of serum complement in the hypocomplementaemic nephritides. Clin Exp Immunol 18(3):391–405
Seino J, vd Wall Bake WL, van Es LA, Daha MR (1993) A novel ELISA assay for the detection of C3 nephritic factor. J Immunol Methods 159(1–2):221–227
Tanuma Y, Ohi H, Hatano M (1990) Two types of C3 nephritic factor: properdin-dependent C3NeF and properdin-independent C3NeF. Clin Immunol Immunopathol 56(2):226–238
Mollnes TE, Ng YC, Peters DK, Lea T et al (1986) Effect of nephritic factor on C3 and on the terminal pathway of complement in vivo and in vitro. Clin Exp Immunol 65(1):73–79
Marinozzi MC, Chauvet S, Le Quintrec M et al (2017) C5 nephritic factors drive the biological phenotype of C3 glomerulopathies. Kidney Int. pii: S0085-2538(17)30309-5
Skattum L, Mårtensson U, Sjöholm AG (1997) Hypocomplementaemia caused by C3 nephritic factors (C3 NeF): clinical findings and the coincidence of C3 NeF type II with anti-C1q autoantibodies. J Intern Med 242(6):455–464
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Skattum, L. (2019). Analysis of C3 Nephritic Factors by ELISA. In: Houen, G. (eds) Autoantibodies. Methods in Molecular Biology, vol 1901. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-8949-2_13
Download citation
DOI: https://doi.org/10.1007/978-1-4939-8949-2_13
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-8948-5
Online ISBN: 978-1-4939-8949-2
eBook Packages: Springer Protocols